CNO Financial Group, Inc. 's CNO reported fourth-quarter 2018 adjusted earnings per share of 36 cents, missing the Zacks Consensus Estimate by 32%. Also, the bottom line declined 41% year over year, mainly due to lower revenues. This downside was also on account of the unfavorable impact of $14.4 million, related to change in the value of investments, which backs the company-owned life insurance and adverse financial markets.
In the quarter under review, CNO Financial's total revenues declined 28.6% year over year to $788 million, missing the Zacks Consensus Estimate by 20.1%, mainly due to lower insurance policy income and net investment income. Quarterly Operational Update
Total collected premiums were $987.3 million, up 5% from the prior-year quarter's level, mainly driven by Bankers Life segment.
New annualized premiums for life and health products amounted to $89.6 million, up 5% from the year-ago period.
First-year collected premiums totaled $435.3 million, up 22% from the year-earlier quarter's tally, primarily banking on the contribution by Bankers Life segment.
CNO Financial Group, Inc. Price and EPS Surprise
CNO Financial Group, Inc. Price and EPS Surprise | CNO Financial Group, Inc. Quote
Quarterly Segment Update
Total collected premiums were $732.1 million, up 12.4% year over year, aided by annuity.
New annualized premiums for life and health products decreased 3% year over year to $42.2 million.
Total collected premiums of $176.3 million were up 4.6% year over year.
New Annualized premiums from life and health products were $30.1 million, up 11.1% from the year-ago quarter's figure.
Pre-tax operating earnings surged 35% year over year, reflecting higher margins on the supplemental health block and a favorable impact of comprehensive annual actuarial review of assumptions.
Total collected premiums were $75.2 million, up 4.4% year over year.
New annualized premiums were $17.3 million, up 16.9% from the amount recorded in the comparable quarter last year.
The pre-tax earnings were $4.8 million, lower by 18.6% from the level in the year-ago period.
Long-Term Care in Run-Off
Total collected premiums were $3.7 million, down 92.5% year over year.
The long-term care business was recaptured in September 2016 and the segment recognized pre-tax operating earnings of $0.3 million in the quarter under review, down 97.2% year over year.
The company expects this segment to report normalized earnings before net realized investment gains (losses) of approximately breakeven over the long term. However, this segment's quarterly results can be volatile.
The segment includes performance of the investment advisory subsidiary and corporate expenses.
Pre-tax loss of $29.7 million in the fourth quarter was wider than $3.3 million loss incurred in the year-ago quarter.
Deteriorating Financial Position
Unrestricted cash and investments held by CNO Financial's holding company were $220 million as of Dec 31, 2018, down 44.5% from the level at 2017 end.
Debt-to-capital ratio was 21.4% as of Dec 31, 2018 compared with 15.9% at the end of 2017.
Securities Repurchase and Divided Update
During the fourth quarter, the company bought back shares worth $40.4 million.
Dividends paid on common stock totaled $16.4 million in the same period.
For the full year, total collected premiums summed $3.8 billion, up 3% from 2017's figure.
First-year collected premiums came in at $1.5 billion, up 8% year over year.
Net operating income per share is $1.83 in 2018, up 4.6% year over year.
For Bankers Life, long-term care interest-adjusted benefit ratio is expected in the band of 74-79%.
For Washington International, supplemental health interest-adjusted benefit ratio is projected in the 55-58% range.
Colonnial Penn is anticipated to deliver earnings of $12-$20 million. However, this segment is projected to incur a loss of $1-$3 million in first-quarter 2019.
Zacks Rank and Performance of Other Multiline Insurers
CNO Financial carries a Zacks Rank #4 (Sell).
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .
Among other players from the insurance industry having reported fourth-quarter earnings so far, the bottom-line results of MetLife, Inc. MET , The Hartford Financial Services Group, Inc. HIG and Radian Group Inc. RDN beat the respective Zacks Consensus Estimate.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Radian Group Inc. (RDN): Get Free Report CNO Financial Group, Inc. (CNO): Get Free Report MetLife, Inc. (MET): Free Stock Analysis Report The Hartford Financial Services Group, Inc. (HIG): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research